396 related articles for article (PubMed ID: 23975375)
1. Swedish experience-based value sets for EQ-5D health states.
Burström K; Sun S; Gerdtham UG; Henriksson M; Johannesson M; Levin LÅ; Zethraeus N
Qual Life Res; 2014 Mar; 23(2):431-42. PubMed ID: 23975375
[TBL] [Abstract][Full Text] [Related]
2. Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States.
Burström K; Teni FS; Gerdtham UG; Leidl R; Helgesson G; Rolfson O; Henriksson M
Pharmacoeconomics; 2020 Aug; 38(8):839-856. PubMed ID: 32307663
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
[TBL] [Abstract][Full Text] [Related]
4. Similar responses to EQ-5D-3L by two elicitation methods: visual analogue scale and time trade-off.
Wang X; Zhuo L; Ma Y; Cai T; Must A; Xu L; Zhuo L
BMC Med Res Methodol; 2020 May; 20(1):118. PubMed ID: 32410582
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the Swedish EQ-5D experience-based value sets in a total hip replacement population.
Nemes S; Burström K; Zethraeus N; Eneqvist T; Garellick G; Rolfson O
Qual Life Res; 2015 Dec; 24(12):2963-70. PubMed ID: 26038221
[TBL] [Abstract][Full Text] [Related]
6. Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study.
Sayah FA; Bansback N; Bryan S; Ohinmaa A; Poissant L; Pullenayegum E; Xie F; Johnson JA
Qual Life Res; 2016 Jul; 25(7):1679-85. PubMed ID: 26659899
[TBL] [Abstract][Full Text] [Related]
7. Experience-based VAS values for EQ-5D-3L health states in a national general population health survey in China.
Sun S; Chen J; Kind P; Xu L; Zhang Y; Burström K
Qual Life Res; 2015 Mar; 24(3):693-703. PubMed ID: 25246184
[TBL] [Abstract][Full Text] [Related]
8. Inequality and heterogeneity in health-related quality of life: findings based on a large sample of cross-sectional EQ-5D-5L data from the Swedish general population.
Teni FS; Gerdtham UG; Leidl R; Henriksson M; Åström M; Sun S; Burström K
Qual Life Res; 2022 Mar; 31(3):697-712. PubMed ID: 34628587
[TBL] [Abstract][Full Text] [Related]
9. Inconsistencies in TTO and VAS values for EQ-5D health states.
Lamers LM; Stalmeier PF; Krabbe PF; Busschbach JJ
Med Decis Making; 2006; 26(2):173-81. PubMed ID: 16525171
[TBL] [Abstract][Full Text] [Related]
10. Reporting and valuing one's own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition.
Ernstsson O; Burström K; Heintz E; Mølsted Alvesson H
Health Qual Life Outcomes; 2020 Dec; 18(1):388. PubMed ID: 33334348
[TBL] [Abstract][Full Text] [Related]
11. Estimating an EQ-5D value set for Malaysia using time trade-off and visual analogue scale methods.
Yusof FA; Goh A; Azmi S
Value Health; 2012; 15(1 Suppl):S85-90. PubMed ID: 22265073
[TBL] [Abstract][Full Text] [Related]
12. Preparatory study for the revaluation of the EQ-5D tariff: methodology report.
Mulhern B; Bansback N; Brazier J; Buckingham K; Cairns J; Devlin N; Dolan P; Hole AR; Kavetsos G; Longworth L; Rowen D; Tsuchiya A
Health Technol Assess; 2014 Feb; 18(12):vii-xxvi, 1-191. PubMed ID: 24568945
[TBL] [Abstract][Full Text] [Related]
13. Multiplicative modelling of EQ-5D-3L TTO and VAS values.
Shafie AA; Vasan Thakumar A
Eur J Health Econ; 2020 Dec; 21(9):1411-1420. PubMed ID: 32892230
[TBL] [Abstract][Full Text] [Related]
14. Concordance among Swedish, German, Danish, and UK EQ-5D-3L Value Sets: Analyses of Patient-Reported Outcomes in the Swedish Hip Arthroplasty Register.
Teni FS; Rolfson O; Berg J; Leidl R; Burström K
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575317
[No Abstract] [Full Text] [Related]
15. Crosswalk algorithms for the conversion of mean EQ-5D indices calculated with different value sets.
Nemes S; Garellick G; Salomonsson R; Rolfson O
Scand J Public Health; 2016 Jul; 44(5):455-61. PubMed ID: 27090196
[TBL] [Abstract][Full Text] [Related]
16. Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden.
Teni FS; Burström K; Devlin N; Parkin D; Rolfson O;
Health Qual Life Outcomes; 2023 Apr; 21(1):34. PubMed ID: 37038172
[TBL] [Abstract][Full Text] [Related]
17. Quality-of-life valuations of advanced breast cancer by New Zealand women.
Milne RJ; Heaton-Brown KH; Hansen P; Thomas D; Harvey V; Cubitt A
Pharmacoeconomics; 2006; 24(3):281-92. PubMed ID: 16519549
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
19. Variations in Patients' Overall Assessment of Their Health Across and Within Disease Groups Using the EQ-5D Questionnaire: Protocol for a Longitudinal Study in the Swedish National Quality Registers.
Teni FS; Rolfson O; Devlin N; Parkin D; Nauclér E; Burström K;
JMIR Res Protoc; 2021 Aug; 10(8):e27669. PubMed ID: 34448726
[TBL] [Abstract][Full Text] [Related]
20. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients.
Kiadaliri AA; Eliasson B; Gerdtham UG
Health Qual Life Outcomes; 2015 Sep; 13():145. PubMed ID: 26374709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
